Vivtex Analysis
What is Vivtex?
First to use intact GI tissue in robotic drug screening
Location
Boston, United States
Employees
11-50
Founded
2018
Product Features & Capabilities
- GI-ORIS™ robotic screening platform for intact GI tissue
- Oral drug delivery system development
- Drug toxicity mitigation testing
- Spatial and temporal drug delivery evaluation
Use Cases
Screen oral drug candidates for absorption in human GI tissue; Test drug toxicity in functional intact tissue; Identify lead formulations with high GI absorption; Develop new oral therapeutics to replace injectable drugs; Evaluate drug delivery timing and location in GI tract
Other Considerations
Invented by MIT Langer Lab; Co-founded by Robert Langer and Dr. Giovanni Traverso; Featured in Nature and StatNews; Partnerships with NIH and Scientific American; Preclinical stage with multiple drug development programs
See something that needs updating? Suggest edits to this profile.